ASSESSING THE FEASIBILITY OF DELIVERING A PRE-IMPLANTATION NURSE-LED EDUCATIONAL INTERVENTION TO PRIMARY PREVENTION IMPLANTABLE CARDIOVERTER DEFIBRILLATOR CANDIDATES: A RANDOMIZED FEASIBILITY TRIAL

2018 ◽  
Vol 34 (10) ◽  
pp. S207
Author(s):  
J. Pannag ◽  
S. Carroll ◽  
M. McGillion ◽  
J. Yost ◽  
L. Martin
Keyword(s):  
Primary Prevention ◽  
Implantable Cardioverter Defibrillator ◽  
Educational Intervention ◽  
Feasibility Trial ◽  
Cardioverter Defibrillator

scholarly journals Survival After Primary Prevention Implantable Cardioverter-Defibrillator Placement Among Patients With Chronic Kidney Disease

2014 ◽  
Vol 7 (5) ◽  
pp. 793-799 ◽  
Author(s):  
Paul L. Hess ◽  
Anne S. Hellkamp ◽  
Eric D. Peterson ◽  
Gillian D. Sanders ◽  
Hussein R. Al-Khalidi ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Primary Prevention ◽  
Kidney Disease ◽  
Implantable Cardioverter Defibrillator ◽  
Cardioverter Defibrillator

Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy

2021 ◽  
Author(s):  
Victor Nauffal ◽  
Peter Marstrand ◽  
Larry Han ◽  
Victoria N Parikh ◽  
Adam S Helms ◽  
...  
Keyword(s):  
Hypertrophic Cardiomyopathy ◽  
Primary Prevention ◽  
Implantable Cardioverter Defibrillator ◽  
Cox Proportional Hazards ◽  
Icd Implantation ◽  
Icd Therapy ◽  
Cardioverter Defibrillator ◽  
Significant Difference ◽  
Implantation Rates ◽  
The Impact

Abstract Aims  Risk stratification algorithms for sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HCM) and regional differences in clinical practice have evolved over time. We sought to compare primary prevention implantable cardioverter defibrillator (ICD) implantation rates and associated clinical outcomes in US vs. non-US tertiary HCM centres within the international Sarcomeric Human Cardiomyopathy Registry. Methods and results We included patients with HCM enrolled from eight US sites (n = 2650) and five non-US (n = 2660) sites and used multivariable Cox-proportional hazards models to compare outcomes between sites. Primary prevention ICD implantation rates in US sites were two-fold higher than non-US sites (hazard ratio (HR) 2.27 [1.89–2.74]), including in individuals deemed at high 5-year SCD risk (≥6%) based on the HCM risk-SCD score (HR 3.27 [1.76–6.05]). US ICD recipients also had fewer traditional SCD risk factors. Among ICD recipients, rates of appropriate ICD therapy were significantly lower in US vs. non-US sites (HR 0.52 [0.28–0.97]). No significant difference was identified in the incidence of SCD/resuscitated cardiac arrest among non-recipients of ICDs in US vs. non-US sites (HR 1.21 [0.74–1.97]). Conclusion  Primary prevention ICDs are implanted more frequently in patients with HCM in US vs. non-US sites across the spectrum of SCD risk. There was a lower rate of appropriate ICD therapy in US sites, consistent with a lower-risk population, and no significant difference in SCD in US vs. non-US patients who did not receive an ICD. Further studies are needed to understand what drives malignant arrhythmias, optimize ICD allocation, and examine the impact of different ICD utilization strategies on long-term outcomes in HCM.

scholarly journals Is Time From Last Hospitalization for Heart Failure to Placement of a Primary Prevention Implantable Cardioverter-Defibrillator Associated With Patient Outcomes?

Circulation ◽  
2018 ◽  
Vol 138 (24) ◽  
pp. 2787-2797 ◽  
Author(s):  
Andrew P. Ambrosy ◽  
Craig S. Parzynski ◽  
Daniel J. Friedman ◽  
Marat Fudim ◽  
Adrian F. Hernandez ◽  
...  
Keyword(s):  
Heart Failure ◽  
Primary Prevention ◽  
Implantable Cardioverter Defibrillator ◽  
Patient Outcomes ◽  
Cardioverter Defibrillator

scholarly journals Impact of early complications on outcomes in patients with implantable cardioverter-defibrillator for primary prevention

Heart Rhythm ◽  
2016 ◽  
Vol 13 (5) ◽  
pp. 1045-1051 ◽  
Author(s):  
Maria Soledad Ascoeta ◽  
Eloi Marijon ◽  
Pascal Defaye ◽  
Didier Klug ◽  
Frankie Beganton ◽  
...  
Keyword(s):  
Primary Prevention ◽  
Implantable Cardioverter Defibrillator ◽  
Early Complications ◽  
Cardioverter Defibrillator
Sign in / Sign up

Export Citation Format

Share Document